Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Eur J Cancer. 2024 May;203:114039. doi: 10.1016/j.ejca.2024.114039. Epub 2024 Mar 30.
Eur J Cancer. 2024.
PMID: 38598922
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study).
Pagani S, Lombardi N, Crescioli G, Vighi GV, Spada G, Romoli I, Andreetta P, Capuano A, Marrazzo E, Marra A, Leoni O, Vannacci A, Venegoni M, Vighi GD; MEREAFaPS Study group.
Pagani S, et al.
Intern Emerg Med. 2021 Apr;16(3):741-748. doi: 10.1007/s11739-020-02521-x. Epub 2021 Jan 4.
Intern Emerg Med. 2021.
PMID: 33392971
Item in Clipboard
Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).
Lombardi N, Crescioli G, Bettiol A, Tuccori M, Capuano A, Bonaiuti R, Mugelli A, Venegoni M, Vighi GD, Vannacci A; MEREAFaPS Study group.
Lombardi N, et al.
Front Pharmacol. 2020 Apr 6;11:412. doi: 10.3389/fphar.2020.00412. eCollection 2020.
Front Pharmacol. 2020.
PMID: 32327995
Free PMC article.
Item in Clipboard
Cite
Cite